Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (NCT07169630) titled 'PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: National Institute of Mental Health (NIMH)
Condition:
Alzheimer s Disease
Mild Cognitive Impairment
Healthy
Intervention:
Drug: 18F-PF974
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: September 24, 2025
Target Sample Size: 90
Countries of Recruitment:
United States
To kn...